Open access
122
Views
62
CrossRef citations to date
0
Altmetric
Original Research
Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
Walter Vincken1 Respiratory Division, University Hospital, UZ Brussel, Free University of Brussels, Brussels, BelgiumCorrespondence[email protected]
, Joseph Aumann2 Longartsenpraktijk, Prins Bisschopssingel, Hasselt, Belgium
, Hungta Chen3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
, Michelle Henley3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
, Danny McBryan4 Novartis Pharma AG, Basel, Switzerland
& Pankaj Goyal4 Novartis Pharma AG, Basel, Switzerland
Pages 215-228
|
Published online: 24 Feb 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.